传染病建模(英文)(Infectious Disease Modelling)

传染病建模(英文)(Infectious Disease Modelling) 知网目次维普目次

  • CSCD
基本信息
  • 主管单位:

    中国科学院

  • 主办单位:

    中国科技出版传媒股份有限公司

  • 国际刊号:

    2468-0427

  • 国内刊号:

    10-1766/R

  • 学科分类:

    基础医学

  • 字数:

    16000-64000

  • 有无基金:

    /有基金 100.0%

  • 周期:

    CN外文-季刊

  • 特殊属性:

    外文期刊

联系信息
  • 电话:

    001-64015921(官网电话)

  • 邮箱:

    wendy.ye@keaipublishing.com(官网邮箱)

  • 复合因子:

    0

  • 综合因子:

    0

  • 收录:

    知网目次,维普目次

  • 级别:

    CSCD

期刊简介

《传染病建模(英文)(Infectious Disease Modelling)》期刊已被查看:

更新频次

单位占比

一作占比

/有基金-100.0%

投稿指南

1、投稿方式:在线投稿。

2、官网网址:

http://www.keaipublishing.com/en/journals/infectious-disease-modelling/

https://www.sciencedirect.com/journal/infectious-disease-modelling

3、投稿网址:

https://www2.cloud.editorialmanager.com/idm/default2.aspx

4、出刊日期:季刊,逢季末月出版。

2024年2月25日星期日

《传染病建模(英文)》期刊信息

【微信公众号“科爱出版”信息】

2021-01-07

欢迎楼一均、何岱海担任Infectious Disease Modelling新副主编!

2020年,Infectious Disease Modelling(IDM)被ESCI收录,同时入选2020年中国科技期刊卓越行动计划高起点新刊项目。

2020年,IDM积极组织并发表关于新型冠状病毒研究成果的特刊,所有文章及时发表在ScienceDirect上,接受下载和引用,推动科学研究。

感谢大家对期刊发展的支持与贡献,IDM主编、副主编及全体编委成员祝大家新年快乐,在新的一年里希望大家一如既往地支持并投稿IDM。

2021年,Infectious Disease Modelling(IDM)迎来了两位新任副主编:楼一均博士,香港理工大学应用数学系副教授;何岱海博士,香港理工大学应用数学系副教授。热烈欢迎两位副教授担任IDM副主编。

Infectious Disease Modelling

Infectious Disease Modelling (IDM)是一份经过同行评审的开放获取期刊,旨在促进数学建模、传染病数据检索和分析以及公共卫生决策支持方面的研究工作。

文章收录内容主要包括:

- Developing new frameworks, models and methodologies including comparisons with existing models, theories and methods to indicate demonstrable advantages;

- Applications of exiting models and methodologies to new infectious diseases and/or public health issues;

- Integrative use of methodologies and interdisciplinary approaches to evaluate intervention programs and to inform surveillance design;

-Developing linkages between data, modelling, analytics and policy.

期刊目前已被DOAJ、ESCI、Embase、PubMed Central、Scopus 收录,并且已经提交了MEDLINE申请,正在接受评估。入选2020年中国科技期刊卓越行动计划高起点新刊项目。所有文章均可在ScienceDirect免费下载阅读。

欢迎投稿

IDM诚挚地邀请相关领域的学者关注期刊并投稿,所有文章将经过严格的同行评审,一经收录将在ScienceDirect平台免费开放获取。

投稿网址:www.editorialmanager.com/IDM

投稿前请仔细阅读“作者指南”。

《传染病建模(英文)》作者指南

【官网信息】

Guide for Authors

INTRODUCTION

Types of paper

Contributions falling into the following categories will be considered for publication: Original Research Papers, Reviews, Short Communications.

Please ensure that you select the appropriate article type from the list of options when making your submission. Authors contributing to special issues should ensure that they select the special issue article type from this list.

Submission checklist

You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:

• E-mail address

• Full postal address

All necessary files have been uploaded:

Manuscript:

• Include keywords

• All figures (include relevant captions)

• All tables (including titles, description, footnotes)

• Ensure all figure and table citations in the text match the files provided

• Indicate clearly if color should be used for any figures in print

Graphical Abstracts / Highlights files (where applicable)

Supplemental files (where applicable)

Further considerations

• Manuscript has been 'spell checked' and 'grammar checked'

• All references mentioned in the Reference List are cited in the text, and vice versa

• Permission has been obtained for use of copyrighted material from other sources (including the Internet)

• A competing interests statement is provided, even if the authors have no competing interests to declare

• Journal policies detailed in this guide have been reviewed

• Referee suggestions and contact details provided, based on journal requirements

For further information, visit our Support Center.

BEFORE YOU BEGIN

Ethics approval and consent to participate

Manuscripts reporting studies involving human participants, human data or human tissue must:

include a statement on ethics approval and consent (even where the need for approval was waived)

include the name of the ethics committee that approved the study and the committee's reference number if appropriate

All materials must adhere to high ethical and animal welfare standards. Any use of animals must be based on ethological knowledge and respect for species-specific requirements for health and well-being. A statement indicating that the protocol and procedures employed were ethically reviewed and approved, and the name of the body giving approval, must be included in the Methods section of the manuscript.

Consent for publication:

If your research or manuscript contains any individual person's data in any form (including any individual details, images or videos), consent for publication must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent for publication.

Declaration of competing interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of competing interest statement using this template and upload to the submission system at the Attach/Upload Files step. Note: Please do not convert the .docx template to another file type. Author signatures are not required. If there are no interests to declare, please choose the first option in the template. More information.

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.

Author contributions

For transparency, we encourage authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review & editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following. More details and an example

……

更多详情:

http://www.keaipublishing.com/en/journals/infectious-disease-modelling/guide-for-authors/


中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。